Europe ASPIRE Award

Pfizer is strongly committed to research in the Haemophilia area and supports medical innovation in Europe through this Competitive Investigator Research Awards Program. The mission of the Haemophilia ASPIRE 2013 is to support basic science, translational and clinical research through a competitive grants programme that advances medical knowledge in the pathogenesis and treatment of both haemophilia A and B and to support academic research. This program provides research grants for studies designed and conducted by non-Pfizer physicians and scientists. AREA OF RESEARCH FOCUS Optimising clinical outcomes for patients with haemophilia, including, but not limited to, pharmacokinetics, inhibitor treatment, global haemostasis tests, quality of life and joint assessment.